Skip Navigation

JNCI Monographs 2000 2000(28):24-29;
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Scadden, D. T.
Right arrow Articles by Cheng, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scadden, D. T.
Right arrow Articles by Cheng, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute Monographs, No. 28, 24-29, 2000
© 2000 Oxford University Press

Hematopoietic Stem Cells in HIV Disease

Presented at the International Symposium on HIV, Leukemia, and Opportunistic Cancers.

David T. Scadden, Hongmei Shen, Tao Cheng

Affiliation of authors: D. T. Scadden, H. Shen, T. Cheng, AIDS Research Center and Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston.

Correspondence to: David T. Scadden, M.D., AIDS Research Center and Cancer Center, Massachusetts General Hospital, 149 13th St., Rm. 5212D, Boston, MA 02129 (e-mail: scadden.david{at}mgh.harvard.edu).

The hematopoietic stem cell has long been hypothesized to be a target of human immunodeficiency virus type-1 (HIV) infection that limits the potential for compensatory immune cell production. Data have recently emerged documenting stem cell dysfunction in HIV disease and indicating that immune recovery from potent antiretroviral therapy is partly driven by new T-cell generation. Effects of HIV on stem cell physiology, however, appear to be indirect, as stem cells are highly resistant to HIV infection. Despite the presence of surface receptors for HIV, the hematopoietic stem cell is not infectible with HIV. However, stem transduction can be achieved with HIV constructs in which the envelope glycoproteins have been replaced by vesicular stomatitis virus G protein. Therefore, hematopoietic stem cells are likely participants in HIV-related cytopenias, but they are spared direct infection and can serve as a resource for cellular therapies for AIDS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.